This research aims to evaluate the long-term efficacy and safety of photobiomodulation in treating dry age-related macular degeneration.
Used multiwavelength photobiomodulation as an intervention
Analyzed participants over a 24-month period
Evaluated visual function and safety outcomes
Photobiomodulation significantly restored visual function
Indicated potential disease-modifying effects in dry AMD
Safety profile remained stable over the 24 months
Abstract
Multiwavelength PBM represents an interventional therapy that restores visual function and has potential disease-modifying effects in intermediate dry AMD.